A First-in-Human Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Neutralization Profile of Two Investigational Long-Acting Anti-SARS-CoV-2 Monoclonal Antibodies
Moullan, Norman, Asiago, Josephat, Stecco, Kathryn, Hadi, Salah, Albizem, Moetaz, Tieu, Holly, Hock, Björn, Fenwick, Craig, Lin, Kai, Lengsfeld, Thomas, Poffenbarger, Lauren, Liu, David, Trono, Didier, Pantaleo, Giuseppe, Venkayya, Rajeev, Bhuyan, Prakash
Published in Infectious diseases and therapy (2024)
Published in Infectious diseases and therapy (2024)
Get full text
Journal Article
360. A First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Neutralization Profile of Two Long-Acting Anti-SARS-CoV-2 Monoclonal Antibodies
Asiago, Josephat, Albizem, Moetaz, Tieu, Holly L, Stecco, Kathryn, Moullan, Norman, Fenwick, Craig, Lin, Kai, Poffenbarger, Lauren, Lengsfeld, Thomas, Liu, David W, Hock, Björn M, Venkayya, Rajeev, Bhuyan, Prakash
Published in Open forum infectious diseases (27.11.2023)
Published in Open forum infectious diseases (27.11.2023)
Get full text
Journal Article